337 related articles for article (PubMed ID: 11160786)
1. Current concepts in the polycystic ovary syndrome.
Dunaif A; Thomas A
Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
[TBL] [Abstract][Full Text] [Related]
2. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
3. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
Franks S; McCarthy MI; Hardy K
Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
[TBL] [Abstract][Full Text] [Related]
5. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
6. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
7. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
Schuring AN; Schulte N; Sonntag B; Kiesel L
Gynakol Geburtshilfliche Rundsch; 2008; 48(1):9-15. PubMed ID: 18209494
[TBL] [Abstract][Full Text] [Related]
8. Genomic variants in polycystic ovary syndrome.
Luque-Ramírez M; San Millán JL; Escobar-Morreale HF
Clin Chim Acta; 2006 Apr; 366(1-2):14-26. PubMed ID: 16337616
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome in adolescents.
Franks S
Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
[TBL] [Abstract][Full Text] [Related]
10. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.
Urbanek M; Sam S; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4191-8. PubMed ID: 17785364
[TBL] [Abstract][Full Text] [Related]
11. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
12. The genetics of polycystic ovary syndrome.
Amato P; Simpson JL
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):707-18. PubMed ID: 15380142
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
Corbould A
Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
[TBL] [Abstract][Full Text] [Related]
14. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
15. Do polycystic ovaries on ultrasound scan indicate decreased insulin sensitivity in sisters of women with polycystic ovary syndrome?
Raskauskiene D; Jones PW; Govind A; Obhrai M; Clayton RN
J Clin Endocrinol Metab; 2005 Apr; 90(4):2063-7. PubMed ID: 15634726
[TBL] [Abstract][Full Text] [Related]
16. Male PCOS equivalent and nutritional restriction: Are we stepping forward?
Di Guardo F; Cerana MC; D'urso G; Genovese F; Palumbo M
Med Hypotheses; 2019 May; 126():1-3. PubMed ID: 31010486
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in patients with polycystic ovary syndrome.
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
[TBL] [Abstract][Full Text] [Related]
18. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
19. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
Kurzrock R; Cohen PR
Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
